Berkshire Hathaway pulls out of AbbVie, Bristol Myers Squibb investments
It looks like Warren Buffett is sticking to ice cream and railroads for the moment.
The billionaire CEO of Berkshire Hathaway backed out of two major holdings in the pharma industry, Forexlive first reported, including a $410 million investment in AbbVie and a $324.4 million stake in Bristol Myers Squibb.